Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1097/HJH.0b013e328344a7de

Type

Journal article

Journal

JOURNAL OF HYPERTENSION

Publication Date

04/2011

Volume

29

Pages

623 - 635

Keywords

angiotensin receptor blockers, cancer incidence, candesartan, clinical trials, irbesartan, losartan, meta-analysis, telmisartan, valsartan